SYNAPTOGENIX, Inc.
1185 Avenue of the Americas, 3rd Floor
New York, New York 10036
April 25, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Doris Gama and Celeste Murphy
| Re: | Synaptogenix, Inc. |
| Registration Statement on Form S-3 | |
Filed April 15, 2022 | |
File No. 333-264325 (the “Registration Statement”) | |
Acceleration Request |
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Synaptogenix, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Wednesday, April 27, 2022, at 4:01p.m., Eastern Time, or as soon as thereafter practicable.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please contact Daniel A. Bagliebter of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6856 with any questions regarding this request.
| Very truly yours, | |
| SYNAPTOGENIX, INC. | |
|
/s/ Robert Weinstein | |
|
Robert Weinstein Chief Financial Officer, Secretary and Executive Vice President |
| cc: | Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. |
| Kenneth R. Koch, Esq. | |
| Daniel A. Bagliebter, Esq. |